Showing results (41-50 of 44) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Cancer Immunology, Immunotherapy : CII|May 22, 2022
Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patientsKentaro Jingushi, Atsunari Kawashima, Takuro Saito, et al.Japanese Journal of Clinical Oncology|February 2, 2024
Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC studyAkira Nagahara, Motohide Uemura, Mototaka Sato, et al.Cancer Treatment and Research Communications|May 29, 2026
Neutrophil-to-lymphocyte ratio and performance status are associated with increased risk of skin toxicity in patients receiving enfortumab vedotin with or without pembrolizumab for metastatic urothelial carcinomaYujiro Hayashi, Atsunari Kawashima, Yoshiyuki Yamamoto, et al.Scientific Reports|December 12, 2025
Real-world efficacy and safety of pembrolizumab plus lenvatinib in patients with metastatic renal cell carcinoma: a multi-institutional retrospective studyTaigo Kato, Yasutomo Nakai, Mototaka Sato, et al.Pageof 5